{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:12:05Z","timestamp":1780078325573,"version":"3.54.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013991","name":"Texas A and M University Health Science Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.hoc.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T09:22:34Z","timestamp":1572254554000},"page":"205-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radiation Therapy for Benign Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Tony Y.","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Abugideiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tanenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narine","family":"Wandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Westergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jane Sudmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0360-3016(96)00024-7","article-title":"The history and evolution of radiotherapy and radiation oncology in Austria","volume":"35","author":"Kogelnik","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib2","series-title":"Radiobiology for the radiologist","author":"Hall","year":"2019"},{"key":"10.1016\/j.hoc.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-035405-4.50012-8","article-title":"Four R's of radiotherapy","volume":"5","author":"Withers","year":"1975","journal-title":"Advances in Radiation Biology"},{"key":"10.1016\/j.hoc.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/09553008914552491","article-title":"The 5Rs of radiobiology","volume":"56","author":"Steel","year":"1989","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.hoc.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-444-63640-9.00008-4","article-title":"Multimodality management of cerebral arteriovenous malformations","volume":"143","author":"Narayanan","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.hoc.2019.09.005_bib9","first-page":"981","article-title":"A\u00a0practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients","volume":"119","author":"Starke","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.hoc.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"649036","DOI":"10.1155\/2014\/649036","article-title":"Cerebral arteriovenous malformations: evaluation and management","volume":"2014","author":"Ajiboye","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.hoc.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa040907","article-title":"The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations","volume":"352","author":"Maruyama","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2019.09.005_bib12","first-page":"744","article-title":"Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients","volume":"62","author":"Sirin","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.hoc.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00381-004-1049-5","article-title":"Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients","volume":"21","author":"Nicolato","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.hoc.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/STROKEAHA.116.013132","article-title":"Risk reduction of cerebral stroke after stereotactic radiosurgery for small unruptured brain arteriovenous malformations","volume":"47","author":"Hanakita","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.wneu.2015.05.012","article-title":"Radiosurgery for cerebral arteriovenous malformations in elderly patients: effect of advanced age on outcomes after intervention","volume":"84","author":"Ding","year":"2015","journal-title":"World Neurosurg"},{"key":"10.1016\/j.hoc.2019.09.005_bib16","first-page":"1015","article-title":"Gamma Knife surgery for incidental cerebral arteriovenous malformations","volume":"121","author":"Yen","year":"2014","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.hoc.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijrobp.2004.09.008","article-title":"Stereotactic proton beam therapy for intracranial arteriovenous malformations","volume":"62","author":"Vernimmen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2005.04.008","article-title":"Treatment outcome after linac-based radiosurgery in cerebral arteriovenous malformations: retrospective analysis of factors affecting obliteration","volume":"77","author":"Zabel","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ijrobp.2003.09.005","article-title":"Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history","volume":"58","author":"Bollet","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/annonc\/mdr386","article-title":"Update on desmoid tumors","volume":"23","author":"Escobar","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0360-3016(97)00334-9","article-title":"The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors","volume":"39","author":"Goy","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ijc.25664","article-title":"A\u00a0nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses","volume":"129","author":"Nieuwenhuis","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.24117","article-title":"Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis","volume":"113","author":"Koskenvuo","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1200\/JCO.2010.33.5489","article-title":"Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation","volume":"29","author":"Salas","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1245\/s10434-013-3197-x","article-title":"Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought","volume":"20","author":"Bonvalot","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.athoracsur.2004.03.015","article-title":"Chest-wall desmoid tumors: results of surgical intervention","volume":"78","author":"Abbas","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hoc.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.1999.17.1.158","article-title":"Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy","volume":"17","author":"Ballo","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2045::AID-CNCR23>3.0.CO;2-F","article-title":"Extremity and trunk desmoid tumors: a multifactorial analysis of outcome","volume":"86","author":"Merchant","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","article-title":"A\u00a0prognostic nomogram for prediction of recurrence in desmoid fibromatosis","volume":"258","author":"Crago","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(98)00285-5","article-title":"Radiation therapy in the management of desmoid tumors","volume":"42","author":"Ballo","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/annonc\/mdt254","article-title":"Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998)","volume":"24","author":"Keus","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0360-3016(02)02926-7","article-title":"External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis","volume":"54","author":"Zlotecki","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib33","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1200\/JCO.2003.05.150","article-title":"Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution","volume":"21","author":"Gronchi","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bjs.10477","article-title":"Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis","volume":"104","author":"Janssen","year":"2017","journal-title":"Br J Surg"},{"issue":"415","key":"10.1016\/j.hoc.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.blo.0000093892.12372.d4","article-title":"Preoperative radiotherapy is effective in the treatment of fibromatosis","author":"O'Dea","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.hoc.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0959-8049(92)90445-8","article-title":"Desmoid tumours treated with triphenylethylenes","volume":"28A","author":"Brooks","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hoc.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1245\/s10434-008-0285-4","article-title":"Desmoids: a revelation in biology and treatment","volume":"16","author":"Francis","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/PL00002371","article-title":"Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years","volume":"177","author":"Adamietz","year":"2001","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hoc.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1753193417695996","article-title":"Radiotherapy in Dupuytren's disease: a systematic review of the evidence","volume":"42","author":"Kadhum","year":"2017","journal-title":"J\u00a0Hand Surg Eur"},{"key":"10.1016\/j.hoc.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0360-3016(96)00421-X","article-title":"Radiotherapy for prevention of disease progression in early-stage Dupuytren's contracture: initial and long-term results","volume":"36","author":"Keilholz","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(00)00745-8","article-title":"Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study","volume":"49","author":"Seegenschmiedt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00066-010-2063-z","article-title":"Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years","volume":"186","author":"Betz","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hoc.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.prro.2015.06.010","article-title":"Patient-reported outcomes after electron radiation treatment for early-stage palmar and plantar fibromatosis","volume":"5","author":"Schuster","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/jdv.12711","article-title":"Radiotherapy with soft X-rays in Dupuytren's disease - successful, well-tolerated and satisfying","volume":"29","author":"Zirbs","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.hoc.2019.09.005_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14312\/2397-8511.2017-1","article-title":"Dosimetric comparison of radiation methods for palmar fibrosis","volume":"2","author":"Meredith","year":"2017","journal-title":"J\u00a0Clin Radiat Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00066-006-1542-8","article-title":"Estimation of cancer risks from radiotherapy of benign diseases","volume":"182","author":"Trott","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hoc.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1530\/eje.0.1460457","article-title":"Graves' ophthalmopathy: a preventable disease?","volume":"146","author":"Bartalena","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.hoc.2019.09.005_bib48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib49","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","article-title":"Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease","volume":"88","author":"Bahn","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2019.09.005_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","article-title":"Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial","volume":"63","author":"Wakelkamp","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.hoc.2019.09.005_bib52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0181-5512(04)96224-9","article-title":"[The role of radiotherapy in Graves' ophthalmopathy]","volume":"27","author":"Jaulerry","year":"2004","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.hoc.2019.09.005_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0950-351X(97)80738-0","article-title":"Treating severe Graves' ophthalmopathy","volume":"11","author":"Bartalena","year":"1997","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/105072502753600232","article-title":"Radiotherapy for Graves' ophthalmopathy: results at one year","volume":"12","author":"Gorman","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.hoc.2019.09.005_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","article-title":"A\u00a0randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy","volume":"89","author":"Prummel","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib56","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","article-title":"Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study","volume":"355","author":"Mourits","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2019.09.005_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-2002-36948","article-title":"Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results","volume":"219","author":"Pitz","year":"2002","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.hoc.2019.09.005_bib58","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib59","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1210\/jc.2009-0376","article-title":"Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis","volume":"94","author":"Stiebel-Kalish","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.86.1.102","article-title":"Does radiotherapy have a role in the management of thyroid orbitopathy? View 1","volume":"86","author":"Cockerham","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.hoc.2019.09.005_bib61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF03345279","article-title":"Relationship between management of hyperthyroidism and course of the ophthalmopathy","volume":"27","author":"Bartalena","year":"2004","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.hoc.2019.09.005_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03345116","article-title":"Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?","volume":"26","author":"Bartalena","year":"2003","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.hoc.2019.09.005_bib63","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00130404-200311000-00007","article-title":"Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatment","volume":"9","author":"Alpert","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.hoc.2019.09.005_bib64","first-page":"852","article-title":"Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University","volume":"61","author":"Kulig","year":"2004","journal-title":"Przegl Lek"},{"key":"10.1016\/j.hoc.2019.09.005_bib65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0360-3016(98)00405-2","article-title":"Place of radiotherapy in the treatment of Graves' orbitopathy","volume":"43","author":"Beckendorf","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib66","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","article-title":"Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study","volume":"111","author":"Wakelkamp","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.hoc.2019.09.005_bib67","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0002-9394(14)76869-2","article-title":"Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy","volume":"112","author":"Miller","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.hoc.2019.09.005_bib68","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2003-030260","article-title":"Long-term safety of orbital radiotherapy for Graves' ophthalmopathy","volume":"88","author":"Marcocci","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.hoc.2019.09.005_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13014-017-0908-7","article-title":"Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy","volume":"12","author":"Li","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib70","first-page":"429","article-title":"Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program","volume":"168","author":"See","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2019.09.005_bib71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2019.09.005_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1470-2045(03)00958-6","article-title":"The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy","volume":"4","author":"Dicker","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.pcan.4500314","article-title":"Gynaecomastia: aetiology and treatment options","volume":"2","author":"Tyrrell","year":"1999","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.hoc.2019.09.005_bib74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","article-title":"Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3","volume":"61","author":"Widmark","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.hoc.2019.09.005_bib75","first-page":"519","article-title":"Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and\/or breast pain?","volume":"184","author":"Ozen","year":"2010","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2019.09.005_bib76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","article-title":"Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial","volume":"6","author":"Perdona","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib77","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","article-title":"Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer","volume":"47","author":"Van Poppel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2019.09.005_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","article-title":"Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia","volume":"60","author":"Tyrrell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib79","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.ijrobp.2012.01.036","article-title":"Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?","volume":"83","author":"Viani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib80","doi-asserted-by":"crossref","first-page":"e0136094","DOI":"10.1371\/journal.pone.0136094","article-title":"Gynecomastia in Patients with Prostate Cancer: A Systematic Review","volume":"10","author":"Fagerlund","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hoc.2019.09.005_bib81","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/030089160409000409","article-title":"Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options","volume":"90","author":"Prezioso","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.hoc.2019.09.005_bib82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1477-7827-9-93","article-title":"Aromatase inhibitors in men: effects and therapeutic options","volume":"9","author":"de Ronde","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.hoc.2019.09.005_bib83","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0360-3016(88)90321-5","article-title":"Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy","volume":"15","author":"Chou","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijrobp.2018.01.096","article-title":"Does prophylactic radiation therapy to avoid gynecomastia in patients with prostate cancer increase the risk of breast cancer?","volume":"101","author":"Aksnessaether","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib85","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1445-2197.2002.02549.x","article-title":"Incidence of heterotopic bone formation after major hip surgery","volume":"72","author":"Neal","year":"2002","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.hoc.2019.09.005_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(94)90519-3","article-title":"Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results","volume":"30","author":"Gregoritch","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib87","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2106\/00004623-197355080-00006","article-title":"Ectopic ossification following total hip replacement. Incidence and a method of classification","volume":"55","author":"Brooker","year":"1973","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.hoc.2019.09.005_bib88","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1302\/0301-620X.79B6.0790959","article-title":"Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study","volume":"79","author":"Matta","year":"1997","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.hoc.2019.09.005_bib89","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s004020050414","article-title":"Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication","volume":"119","author":"Kienapfel","year":"1999","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.hoc.2019.09.005_bib90","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2003.11.015","article-title":"Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials","volume":"60","author":"Pakos","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib91","first-page":"74","article-title":"The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement","volume":"15","author":"Pakos","year":"2010","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.hoc.2019.09.005_bib92","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0360-3016(01)01640-6","article-title":"Radiation prophylaxis for heterotopic ossification about the hip joint--a multicenter study","volume":"51","author":"Seegenschmiedt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1148\/radiology.168.3.3136510","article-title":"Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation","volume":"168","author":"Lo","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2019.09.005_bib94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2106\/00004623-199274020-00005","article-title":"Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field","volume":"74","author":"Pellegrini","year":"1992","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.hoc.2019.09.005_bib95","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2106\/00004623-199504000-00013","article-title":"Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray","volume":"77","author":"Healy","year":"1995","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.hoc.2019.09.005_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(97)00285-X","article-title":"Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy","volume":"39","author":"Seegenschmiedt","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib97","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0883-5403(03)00265-1","article-title":"The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study","volume":"18","author":"Padgett","year":"2003","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.hoc.2019.09.005_bib98","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1302\/0301-620X.85B5.13970","article-title":"Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion","volume":"85","author":"Burd","year":"2003","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.hoc.2019.09.005_bib99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.prro.2011.06.005","article-title":"Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification","volume":"2","author":"Mourad","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0889-8588(18)30650-6","article-title":"Histiocytosis X. Langerhans' cell histiocytosis","volume":"1","author":"Osband","year":"1987","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2019.09.005_bib101","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","article-title":"Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells","volume":"184","author":"Allen","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.hoc.2019.09.005_bib102","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.hoc.2019.09.005_bib103","first-page":"99","article-title":"The variable presentation and natural history of Langerhans cell histiocytosis","volume":"19","author":"Buckwalter","year":"1999","journal-title":"Iowa Orthop J"},{"key":"10.1016\/j.hoc.2019.09.005_bib104","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0959-8049(99)00039-8","article-title":"The histiocytoses: the fall of the tower of babel","volume":"35","author":"Arceci","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hoc.2019.09.005_bib105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"Risk factors for diabetes insipidus in langerhans cell histiocytosis","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.hoc.2019.09.005_bib106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2106\/00004623-199802000-00009","article-title":"Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone)","volume":"80","author":"Yasko","year":"1998","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.hoc.2019.09.005_bib107","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","article-title":"Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification","volume":"111","author":"Gadner","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2019.09.005_bib108","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2019.09.005_bib109","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1067\/mpd.2001.111331","article-title":"A\u00a0randomized trial of treatment for multisystem Langerhans' cell histiocytosis","volume":"138","author":"Gadner","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.hoc.2019.09.005_bib110","first-page":"663","article-title":"Adult langerhans cell histiocytosis of bones : a rare cancer network study","volume":"76","author":"Atalar","year":"2010","journal-title":"Acta Orthop Belg"},{"key":"10.1016\/j.hoc.2019.09.005_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0936-6555(05)80770-8","article-title":"Histiocytosis X: does radiotherapy still have a role?","volume":"4","author":"el-Sayed","year":"1992","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.hoc.2019.09.005_bib112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mpo.2950180203","article-title":"Radiation therapy in the management of Langerhans cell histiocytosis","volume":"18","author":"Selch","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib113","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/00007632-200207010-00007","article-title":"Eosinophilic granuloma of the cervical spine","volume":"27","author":"Bertram","year":"2002","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.hoc.2019.09.005_bib114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mpo.2950180407","article-title":"Histiocytosis X in bone only","volume":"18","author":"Berry","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijrobp.2017.10.053","article-title":"Outcome after radiation therapy for langerhans cell histiocytosis is dependent on site of involvement","volume":"100","author":"Laird","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib116","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/01.SMJ.0000146548.89694.8A","article-title":"Radiotherapy dose fractionation in pediatric Langerhans cell histiocytosis","volume":"97","author":"Jahraus","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.hoc.2019.09.005_bib117","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0360-3016(92)90029-H","article-title":"Radiation therapy in children: continued need to assess risk versus gain","volume":"23","author":"Greenberger","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2019.09.005_bib118","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00043426-198100320-00008","article-title":"The role of radiation therapy in the management of children with histiocytosis X","volume":"3","author":"Richter","year":"1981","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib119","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/COC.0b013e318281d6ce","article-title":"Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis","volume":"37","author":"Kotecha","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1096-911X(199707)29:1<36::AID-MPO7>3.0.CO;2-T","article-title":"Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?","volume":"29","author":"Rosenzweig","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.hoc.2019.09.005_bib121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0360-3016(92)90006-4","article-title":"Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis","volume":"23","author":"Minehan","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819301200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858819301200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:13:12Z","timestamp":1760184792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858819301200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889858819301200"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2019.09.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Benign Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}